UA112748C2 - Combination pharmaceutical composition and methods of treating and preventing the infectious diseases - Google Patents
Combination pharmaceutical composition and methods of treating and preventing the infectious diseasesInfo
- Publication number
- UA112748C2 UA112748C2 UAA201300103A UAA201300103A UA112748C2 UA 112748 C2 UA112748 C2 UA 112748C2 UA A201300103 A UAA201300103 A UA A201300103A UA A201300103 A UAA201300103 A UA A201300103A UA 112748 C2 UA112748 C2 UA 112748C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treating
- preventing
- pharmaceutical composition
- methods
- infectious diseases
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to at least one cytokine and b) an activated-potentiated form of an antibody to at least one receptor, and methods of treating and preventing the infectious diseases, including bacterial infections caused by different infectious agents such as pseudotuberculosis, whooping cough, yersiniosis, pneumonitis of different etiology, and acute and chronic viral infections such as acute respiratory tract infections, influenza of different types, acute viral hepatitis А, В, С and other types of hepatitis, the diseases and conditions caused by HIV or associated with HIV, including AIDS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010133041/15A RU2010133041A (en) | 2010-08-06 | 2010-08-06 | INTEGRATED MEDICINE AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS |
PCT/IB2011/002470 WO2012017328A2 (en) | 2010-08-06 | 2011-07-15 | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112748C2 true UA112748C2 (en) | 2016-10-25 |
Family
ID=45854177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201300103A UA112748C2 (en) | 2010-08-06 | 2011-07-15 | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU2010133041A (en) |
UA (1) | UA112748C2 (en) |
-
2010
- 2010-08-06 RU RU2010133041/15A patent/RU2010133041A/en unknown
-
2011
- 2011-07-15 UA UAA201300103A patent/UA112748C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2010133041A (en) | 2012-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2503066A8 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
EA026667B9 (en) | Pharmaceutical composition for treating hepatitis c virus | |
PH12015501881A1 (en) | Amide compounds for the treatment of hiv | |
GEP20156263B (en) | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof | |
PH12015501017A1 (en) | Alternative uses for hbv assembly effectors | |
EA201691837A1 (en) | ANTI-VIRAL AGENTS AGAINST HEPATITIS B | |
UA113956C2 (en) | PIRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | |
WO2012140127A3 (en) | Method for priming of t cells | |
MX2014009546A (en) | Antiviral compounds with a heterotricycle moiety. | |
MX2015012397A (en) | Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy. | |
GB2497453A (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
EA201490213A1 (en) | BENZOFURANE CONNECTIONS FOR THE TREATMENT OF INFECTIONS BY THE HEPATITIS C VIRUS | |
PH12016500465A1 (en) | Deoxynojirimycin derivatives and methods of their using | |
MY191515A (en) | Tenofovir monobenzyl ester phosphamide prodrug, preparation method and use thereof | |
WO2015058772A3 (en) | Novel hcv culture systems and direct-acting antiviral sensitivity | |
UA118542C2 (en) | Immunogenic compounds comprising hiv gp41 peptide coupled to crm197 carrier protein | |
EA201400235A1 (en) | VACCINES AGAINST FLU BASED ON H5 | |
WO2016195522A3 (en) | Antiviral composition | |
WO2015086738A3 (en) | Hiv vaccine | |
UA112748C2 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
MY179706A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
WO2018056528A3 (en) | Influenza b vaccine | |
UA113389C2 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv | |
EA202092602A2 (en) | -D-2'-DESOXY-2 '- FLUORINE-2' - C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR THE TREATMENT OF HCV-INDUCED DISEASES | |
UA111703C2 (en) | INFLUENCES OF Flu Virus Replication |